New blood test combo may spot sepsis death risk

NCT ID NCT06640504

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested whether combining standard infection markers (like lactate, CRP, and procalcitonin) with albumin levels could better predict death in sepsis patients in a surgical ICU. Researchers looked at 30 patients and calculated three ratios (lactate-to-albumin, CRP-to-albumin, and procalcitonin-to-albumin). The goal was to see if these ratios improve on traditional tests for spotting high-risk patients.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to

If the approach proves accurate, it could give doctors a simple, low-cost way to identify high-risk sepsis patients earlier.

What could go wrong

This was a very small study (30 people) and only looked back at existing data. Larger, real-time tests are needed to confirm if the method truly helps.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SEPSIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

infectious disease with sepsis Sepsis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Benha University

    Banhā, El Qalyoubia, 13511, Egypt